Aimia (AIM) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
25 Dec, 2025Executive summary
Achieved strong Q4 and FY2024 results, meeting or exceeding guidance, with significant revenue and adjusted EBITDA growth driven by core holdings Bozzetto and Cortland.
Board transition saw Rhys Summerton replace Thomas Finke as Executive Chairman, reflecting succession planning and cost reduction.
Completed major milestones: normal course issuer bid, cooperation agreement with largest shareholder, and substantial issuer bid (SIB) to recapitalize and unlock shareholder value.
FY2024 results were in line with guidance, and 2025 guidance builds on momentum with a focus on cost-cutting and improved performance at core holdings.
$32.9M cash earn-out received from PLM divestiture.
Financial highlights
Q4 2024 consolidated revenue grew 27% year-over-year to $127.2M; FY2024 revenue reached $500.8M, up 72%.
Gross profit increased 31% to $31.1M in Q4; gross margin improved to 24.4% in Q4 and 26.4% for FY2024.
Adjusted EBITDA rose to $17.3M in Q4 (from a loss of $1.1M); FY2024 adjusted EBITDA was $51.3M (vs. $7.8M in FY2023).
Net loss improved to $41.2M in Q4 (from $59M loss); FY2024 net loss was $53.5M (vs. $188.6M loss in FY2023), mainly due to non-cash items.
Ended Q4 with $95.4M in cash and cash equivalents.
Outlook and guidance
FY2025 adjusted EBITDA guidance for Bozzetto and Cortland combined is $88–$95M, representing up to 14% growth from 2024.
Holding company costs targeted below $11M, with further cost-saving opportunities anticipated.
Focus on sustaining momentum, cost management, and liquidity preservation in 2025.
Latest events from Aimia
- Sale yields CAD 265–271M for debt reduction, new investments, and tax loss utilization.AIM
M&A announcement27 Feb 2026 - Q2 2024 delivered higher adjusted EBITDA, strong liquidity, and active capital return initiatives.AIM
Q2 20241 Feb 2026 - Q3 2024 saw double-digit revenue and EBITDA growth, strategic alignment, and strong liquidity.AIM
Q3 202415 Jan 2026 - Q1 revenue and EBITDA surged on cost cuts, core growth, and a $53.8M issuer bid gain.AIM
Q1 202526 Nov 2025 - Revenue and adjusted EBITDA rose in Q2 2025, with cost targets lowered amid tariff headwinds.AIM
Q2 202523 Nov 2025 - Returned to profit with strong EBITDA, cash flow, and 8.9% share reduction.AIM
Q3 202512 Nov 2025